Nesburn A B, Lowe G H, Lepoff N J, Maguen E
Ophthalmology. 1984 Oct;91(10):1188-92. doi: 10.1016/s0161-6420(84)34170-7.
Six eyes of four patients with Thygeson's superficial punctate keratitis were treated with trifluridine 1% drops. Five of the six treated eyes responded favorably to topical trifluridine therapy. Symptoms and later the signs of the disease disappeared, but more slowly than observed following topical corticosteroid therapy. One patient with an 11-year history of topical corticosteroid dependence for clearing of lesions was treated successfully with trifluridine, and his eyes have remained clear for over one year without therapy. Mild irritation and transient limbal follicle formation were the only recognized side effects. Trifluridine is thus an effective and safe alternative to corticosteroids in the treatment of this condition and may offer a means of treating the steroid-dependent patient.
对4例蒂格森表层点状角膜炎患者的6只眼睛使用1%的三氟胸腺嘧啶核苷滴眼液进行治疗。6只接受治疗的眼睛中有5只对局部使用三氟胸腺嘧啶核苷治疗反应良好。疾病的症状及随后的体征消失,但比局部使用皮质类固醇治疗后观察到的消失速度要慢。1例有11年局部使用皮质类固醇清除病变病史的患者用三氟胸腺嘧啶核苷治疗成功,其眼睛在未接受治疗的情况下保持清晰超过1年。仅观察到轻度刺激和短暂的角膜缘滤泡形成等副作用。因此,在治疗这种疾病方面,三氟胸腺嘧啶核苷是皮质类固醇的一种有效且安全的替代药物,并且可能为治疗依赖类固醇的患者提供一种方法。